July - September 2019, Volume 15, Issue 3

Shamas S, Rani S, Afsheen S, Shahab M, Ejaz R, Sadia H, Khan L, Rehman TU, Roshan S, Mayo A

Changes in Irisin Release in Response to Peripheral Kisspeptin-10 Administration in Healthy and Obese Adult Men

Acta Endo (Buc) 2019, 15 (3): 283-288
doi: 10.4183/aeb.2019.283

recently. However, the nature of the signals that may connect body fat/muscle tissues with the central nervous system governing energy homeostasis remains to be elucidated. Objective. The present study was designed to investigate the effects of peripheral kisspeptin-10 administration on irisin release in human males. Subjects and methods. Kisspeptin-10 was administered to normal weight (n=8) and obese (n=8) men. Sequential blood sampling was performed for 30 minutes pre and 210 minutes post kisspeptin injection at 30 minutes interval. ELISA kit was used to detect plasma irisin levels. Results. There is a significant (P<0.0001) effect of Kisspeptin-10 administration on irisin release in both normal weight and obese participants. Mean irisin levels (96.24 ± 1.351 ng/mL) at 210 minutes were significantly (P<0.0001) enhanced as compared to pre-kisspeptin (59.18 ± 4.815 ng/ mL) in normal weight subjects. In obese subjects mean irisin levels (75.76 ± 4.06 ng/mL) were significantly (P<0.0001) elevated at 180 minutes post-kisspeptin when compared with pre-kisspeptin irisin levels (41.28 ± 2.89 ng/mL). Conclusion. Our findings suggest that kisspeptin may have a novel therapeutic potential to induce irisin release in humans which may have anti-obesity effects.

Keywords: Obesity, Kisspeptin-10, Metabolism, Irisin.

Correspondence: Shazia Shamas, Quaid-I-Azam University, Laboratory of Endocrinology, Department of Animal Sciences, Islamabad, Fedral, 45320, Pakistan, E-mail: dr.shazia@uog.edu.pk